The Journal of
Clinical Psychiatry

Schizophrenia/Schizoaffective Disorders

Article July 16, 2007

Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

Peter J. Weiden; Sheldon H. Preskorn; Peter A. Fahnestock; Daniel Carpenter; Ruth Ross; John P. Docherty

J Clin Psychiatry 2007;68(suppl 7):1-44

Article Abstract

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Article

Psychotropic Medication Monitoring

February 21, 2019

Psychotropic medications provide therapeutic benefits but also carry iatrogenic risks. Medication monitoring helps minimize this risk. This CME journal article offers clinicians a review of guidelines and presents monitoring...

Matthew A. Schreiber, Stephanie C. Armstrong, Jesse D. Markman

Article

Acute Blood Pressure Changes With Antipsychotic Use

July 19, 2018

Could administration of certain antipsychotic medications be associated with significant acute blood pressure changes? The authors of this study attempted to answer this question by investigating blood pressure changes...

Kristin A. Parks, Clayton G. Parks, Johnathon P. Yost, et al

Article

Adherence to Follow-Up in First-Episode Psychosis: Ethnicity Factors

June 7, 2018

Do visible minority patients have poorer service engagement and follow-up in mental health care in Canada? The objective of this study was to determine whether visible minority patients with...

Katerina Nikolitch, Andrew Ryder, G. Eric Jarvis

Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

ELSEWHERE:

FOLLOW US:

Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

Related Articles

Psychotropic Medication Monitoring

Acute Blood Pressure Changes With Antipsychotic Use

Adherence to Follow-Up in First-Episode Psychosis: Ethnicity Factors

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles